BioCentury
ARTICLE | Clinical News

Autologous umbilical cord blood: Phase I started

February 27, 2012 8:00 AM UTC

Cord Blood Registry began an open-label, U.S. Phase I trial to evaluate a single dose of 6 million cells/kg intravenous autologous umbilical cord blood stem cells in 10 children ages 6 weeks to 18 mon...